What is Acne Vulgaris: A Clinical Guide to Causes, Classifications, and Dermatologist Backed Treatments

What is Acne Vulgaris: A Clinical Guide to Causes, Classifications, and Dermatologist Backed Treatments

✓ Dermatologist Reviewed • Updated Oct 2026 • 7-min read

What Is Acne? Causes, Types & Evidence-Based Treatments

Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit – hair follicle + oil gland. Not just teens: 40% of women 30-39 still have acne due to hormones. Learn 4 pillars, 6 lesion types & gold-standard treatments.

Acne Vulgaris: Global Burden – At a Glance

9.4%Global prevalence – 8th most prevalent disease
722 / 100kAge-standardized rate 2023 – ↑ 63.6% since 1990
27.1%Adolescents 15-19 – peak age group
40%Women 30-39 continue with post-adolescent acne
95%Develop some scarring – psychosocial burden high
101 studiesShow anxiety/depression link – Layton et al., 2026 review

A study by Boey et al., 2025 stated that global age-standardized prevalence of acne vulgaris reached 721.99 per 100,000 in GBD 2023 analysis.

Understanding the Pilosebaceous Unit

The pilosebaceous unit is the hair follicle plus its attached sebaceous (oil) gland. When this unit becomes overactive, sticky skin cells, sebum, and inflammation work together to form acne lesions.

The Four Pillars of Acne Pathogenesis

Every acne lesion, from a tiny blackhead to a painful deep cyst, is driven by a combination of these four physiological factors:

  • 1. Follicular Hyperkeratinization: Lining of pore sheds cells too rapidly. Instead of sloughing off, dead cells stick together, creating a physical plug.
  • 2. Excessive Sebum Production: Driven by androgens, sebaceous glands produce excess sebum, trapping clumped dead cells inside follicle.
  • 3. Proliferation of C. acnes: Anaerobic bacterium feeds on trapped sebum within clogged pore, multiplying in oxygen-deprived environment.
  • 4. Inflammation & Immune Response: As bacterial colony expands, immune response sends white blood cells, resulting in redness, swelling, heat, pus.
Four Pillars of Acne Pathogenesis - Hyperkeratinization, Excess Sebum, C. acnes Proliferation, Inflammation

A study by Zaenglein et al., 2024 stated that acne management should target multiple pathogenic mechanisms, with strong support for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline.

The 6 Types of Acne Lesions

Non-Inflammatory (Grade I-II)

  • Closed Comedones (Whiteheads): Pore completely blocked by keratin and sebum below skin surface. Remains closed, contents white/flesh-colored.
  • Open Comedones (Blackheads): Pore remains open to air. Sebum + dead cells oxidize when exposed to oxygen, turning dark brown/black. Not dirt.
Whiteheads vs Blackheads - Closed vs Open Comedones - Not Dirt It's Oxidation

Inflammatory (Grade III-IV)

  • Papules: Small, tender red bumps – localized inflammation breaking down follicular wall.
  • Pustules: Similar to papules but topped with yellowish head filled with pus.
  • Nodules: Large, solid, painful lumps deep beneath skin – high risk scarring.
  • Cysts: Severe, painful, pus-filled lesions deep under skin. Most advanced form – requires immediate medical intervention.

Top Dermatologist-Recommended Treatments – AAD Guidelines

Effective therapy addresses root pathogenic factors, not just drying surface.

Active IngredientClinical Target & Best Use
Salicylic Acid (BHA) 0.5-2% OTCUnclogs sticky pores from inside. Best for blackheads, whiteheads, mild congestion.
Benzoyl Peroxide 2.5-10% OTCKills C. acnes via rapid oxidation. Best for red inflammatory papules and pustules.
Adapalene / Tretinoin 0.1-0.05% RxRegulates cell turnover to stop plugging. Best for all acne types, anti-ageing, scar prevention.
Azelaic Acid 10% OTC – 20% RxCalms redness and fades dark acne marks. Best for sensitive, inflamed skin.
Spironolactone Oral RxBlocks androgen at oil gland. Best for hormonal jawline breakouts in women.
Isotretinoin Oral RxShuts down oil by shrinking oil glands. Best for severe, scarring, cystic acne.

A study by Leung et al., 2023 stated that combination of topical retinoid plus benzoyl peroxide is superior to monotherapy for mild to moderate acne.

Designing a Non-Comedogenic Daily Skincare Routine

When you introduce powerful actives, protecting skin barrier is top priority. Stripping lipid layer causes emergency oil overproduction.

  • AM: Gentle cleanser (pH 5.5) → Azelaic / Salicylic (alternate) → Moisturizer with ceramides → Sunscreen SPF 50
  • PM: Double cleanse if makeup → Retinoid (adapalene) → Moisturizer → Spot benzoyl peroxide
  • Rules: No picking, 44% adherence gap, introduce one active every 2 weeks.
Acne Skincare Routine 4 Steps - Cleanse Gently, Apply Treatments, Hydrate Moisturise, Protect with SPF 30
Pharmacist Tip: Avoid comedogenic ingredients: Isopropyl Myristate, Coconut Oil (rating 4), Sodium Lauryl Sulfate if sensitive. Use ceramides + hyaluronic acid for barrier.

FAQs

What is the best first-line acne treatment?

Topical therapy first-line, especially benzoyl peroxide and topical retinoids, sometimes in combination per AAD 2024 guidelines.

When should acne be treated with isotretinoin?

Severe nodulocystic acne, scarring, failed oral antibiotics + topical combos after 3 months, or significant psychosocial impact.

Can acne leave permanent marks?

Yes. 95% develop some scarring, plus post-inflammatory hyperpigmentation and erythema. Early retinoid + azelaic acid reduces risk.

Are antibiotics enough on their own?

No – never monotherapy. Always combine with benzoyl peroxide to prevent resistance. Limit to 3-4 months.

A study by Zaenglein et al., 2024 stated that topical antibiotics should not be used as monotherapy due to resistance risk.

Is spironolactone useful for acne?

Yes for women with jawline hormonal acne, irregular cycles, or PCOS. Dose 50-100mg daily. Requires K+ monitoring.

Regional Variations – Why US Has Higher Rates

Country/RegionPrevalence per 100kvs Global
🇺🇸 United States1,654↑ 128% higher
🇩🇪 Germany1,242↑ 72%
🇬🇧 United Kingdom1,157↑ 60%
🌍 Global Average722—
🇮🇳 India284↓ 61% lower

References – Harvard with Clickable DOI

  1. Zaenglein et al., 2024 – 10.1016/j.jaad.2023.07.018
  2. Leung et al., 2023 – 10.1136/dtb.2023.000051
  3. Boey et al., 2025 – GBD 2023 prevalence
  4. Layton et al., 2026 – Psychosocial impact 101 studies
  5. StatPearls 2023 – NCBI Acne Vulgaris
Was this article helpful?
1 vote · Your choice helps us improve